Skip to main content
SpringerLink
Log in
Book cover

Family Medicine pp 780–787Cite as

Diseases of the Liver

  • Chapter

  • 35 Accesses

Abstract

The liver is vulnerable to injury from viral agents and to exposure to ingested and inhaled toxins. The usual result of injury is an inflammatory reaction known as hepatitis. Hepatitis may be classified as acute or chronic.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985;122:226–33.

    PubMed  CAS  Google Scholar 

  2. Mclntyre M. Clinical presentation of acute viral hepatitis. Br Med Bull 1990;46:533–47.

    Google Scholar 

  3. Tozan N, Forbes A, Anderson MG, Murray-Lyon IM. Safety of alcohol consumption after acute viral hepatitis. Lancet 1991;337:1079–80.

    Article  Google Scholar 

  4. Farero MS, Maynard JE, Leger RT, et al. Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med 1979;91:872–4.

    Article  Google Scholar 

  5. Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993;12:433–7.

    Article  PubMed  CAS  Google Scholar 

  6. McMahon BJ, Alward WLM, Hall BD, et al. Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599–603.

    Article  PubMed  CAS  Google Scholar 

  7. Bacon BR. Managing chronic hepatitis: recent advances in diagnosis and treatment. Postgrad Med 1991;90:103–12.

    PubMed  CAS  Google Scholar 

  8. Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423–41.

    PubMed  CAS  Google Scholar 

  9. Alter MJ. The detection, transmission and outcome of hepatitis C virus infection. Infect Agents Dis 1993;2:155–66.

    PubMed  CAS  Google Scholar 

  10. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294–7.

    Article  PubMed  CAS  Google Scholar 

  11. Lynch-Salamon DI, Combs CA. Hepatitis C in obstetrics and gynecology. Obstet Gynecol 1992;79:621–9.

    PubMed  CAS  Google Scholar 

  12. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494–500.

    Article  PubMed  CAS  Google Scholar 

  13. Williams AE, Dodd RY. The serology of hepatitis C virus in relation to posttransfusion hepatitis. Ann Clin Lab Sci 1990; 20:192–9.

    CAS  Google Scholar 

  14. Koretz RL, Stone O, Gitnick GI. The long-term course of non-A, non-B posttransfusion hepatitis. Gastroenterology 1980;79:893–8.

    PubMed  CAS  Google Scholar 

  15. Holt DA, Baran DA, Ochler RL, Sinnott IV. Delta hepatitis: a diagnostic algorithm. Infect Med 1993;10:23–9.

    Google Scholar 

  16. Kools AM. Hepatitis A, B, C, D and E: update on testing and treatment. Postgrad Med 1992;91:109–14.

    PubMed  CAS  Google Scholar 

  17. Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989;321:1501–6.

    Article  PubMed  CAS  Google Scholar 

  18. Korenman J, Baker B, Waggoner J, et al. Long term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629–34.

    Article  PubMed  CAS  Google Scholar 

  19. Centers for Disease Control. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39:(RR-2):l–26.

    Google Scholar 

  20. Noskin GA. Prevention, diagnosis and management of viral hepatitis A guide for primary care physicians. Arch Fam Med 1995;4:923–34.

    Article  PubMed  CAS  Google Scholar 

  21. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: the need for alternative vaccinations strategies. JAMA 1990;263:1218–22.

    Article  PubMed  CAS  Google Scholar 

  22. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991; 40(RR-13):1–19.

    Google Scholar 

  23. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319:1639–50.

    Article  PubMed  CAS  Google Scholar 

  24. Sorensen TIA, Orholm M, Bensten KD, et al. Prospective evaluation of alcohol abuse and alcoholic liver disease in men as predictors of development of cirrhosis. Lancet 1984; 1:241–3.

    Article  Google Scholar 

  25. Norton R, Batey R, Dwyer R, MacMahon S. Alcohol consumption and the risk of alcohol-related cirrhosis in women. BMJ 1987;295:80–2.

    Article  PubMed  CAS  Google Scholar 

  26. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12–15.

    Article  PubMed  CAS  Google Scholar 

  27. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995; 333:1118–27.

    Article  PubMed  CAS  Google Scholar 

  28. Duscheiko GM. Hepatocellular carcinoma associated with chronic viral hepatitis: aetiology, diagnosis and treatment. Br Med Bull 1990;46:492–511.

    Google Scholar 

  29. Simonetti RG, Calogero C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992;116:97–102.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael L. Parchman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health Sciences University, Portland, OR, 97201, USA

    Robert B. Taylor M.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Family Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA

    Alan K. David M.D. (The Fred Lazarus, Jr., Professor and Director) (The Fred Lazarus, Jr., Professor and Director)

  3. Department of Family Medicine, St. John’s Mercy Medical Center, St. Louis, MO, 63141, USA

    Thomas A. Johnson Jr. M.D. (Chairman) (Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. Department of Family Medicine, University of California—Irvine College of Medicine, Orange, CA, 92697, USA

    Joseph E. Scherger M.D., M.P.H. (Associate Dean for Primary Care and Chair) (Associate Dean for Primary Care and Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Parchman, M.L. (1998). Diseases of the Liver. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_90

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2947-4_90

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2949-8

  • Online ISBN: 978-1-4757-2947-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation